Making Things Possible at Goldman Sachs: 2022 Summer Internship Program

Ready to start your application?

Apply now for our Summer 2022 Programs


Helping AI Conquer Cancer

Goldman Sachs is helping drive the research as advanced, accurate artificial intelligence tools are applied to cancer diagnosis.

In partnership with teams across Goldman Sachs, our Growth Equity team invests in early-stage companies with a focus on technology and innovation as a core service or differentiating advantage. Paige AI, a spin-out from Memorial Sloan Kettering Cancer Center, has created AI-driven digital pathology tools used to help diagnose and treat cancer in clinical and research settings. Since 2020, we have invested $30 million in equity in the startup.

The investment will give Paige AI critical funding to expand its research and development and corporate infrastructure. With expertise and advice from our investing team, Paige is now positioned to grow and scale their business for the future. And AI is ready to combat cancer.

Possibilities Stories

How are we making things possible for our people, clients and communities?

The Evolution of Capital Markets in Europe

Building the Leading Consumer Banking Platform

The Evolution of Capital Markets in Europe

Investing in a Sustainable Future

The Evolution of Capital Markets in Europe

Pioneering a New Age of Bond Trading

The Evolution of Capital Markets in Europe

Structuring a Winning Sports Transaction

The Evolution of Capital Markets in Europe

Breakthrough Success in Emerging Markets

The Evolution of Capital Markets in Europe

Empowering women to reach their full potential